CD19 and B-cell non-Hodgkin lymphoma: The two targets of anti-CD19/CD22 CAR T cells, CD19 and CD22, are commonly expressed on B cell lymphomas, whereas those receptors are not expressed on other cell types including hematopoietic stem cells.150